Tuesday, March 10, 2026

PBM Industry Update 2026: Trends, Challenges, and What’s Ahead (NEW Live Video Webinar)

Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels, for his latest exclusive video webinar:


This event will be broadcast live on:
Friday, April 10, 2026
12:00 p.m. to 1:30 p.m. ET

Dr. Fein will be joined by Bryce Platt, a Director at DCI and an expert on PBMs' contractual and business relationships with plan sponsors.

The webinar will be broadcast live from the Drug Channels studio in beautiful downtown Philadelphia. It is part of The Drug Channels 2026 Video Webinar Series.

Register Now


WHAT YOU WILL LEARN


Join industry expert Adam J. Fein, Ph.D., and his colleague Bryce Platt for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Drawing from the brand-new 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, they will provide invaluable insights to help you and your team stay informed about this rapidly evolving market.

Adam and Bryce will share their expert analysis on critical industry developments, including:
  • The competitive landscape of major PBMs, with exclusive new market share data from DCI
  • Key business trends among leading PBMs and their impact on the market
  • PBMs’ expanding role in specialty pharmacy and how it’s reshaping the industry
  • Exclusive insights into the Federal Trade Commission’s settlement with Express Scripts
  • The outlook for the rebate system and the emergence of the Net Pricing Drug Channel
  • What the Consolidated Appropriations Act of 2026 (CAA) means for PBMs’ profits and business strategies
  • The evolving role of independent PBMs and their market positioning
  • How health-system-owned PBMs are changing the game
  • Fresh data on plan sponsors’ perspectives on their PBM partners
  • Key takeaways from PBMs’ 2026 commercial formularies
  • The coming shifts in PBM compensation models
  • The risks and rewards of PBM-affiliated private-label products and GPOs
  • Latest developments in the 340B Drug Pricing Program
  • State and federal PBM regulations: What’s ahead?
  • Emerging controversies, challenges, and threats to watch in the industry
And much more!

As always, the presenters will clearly distinguish their opinions and interpretations from the objective facts and data.

This 90-minute video webinar will feature a dedicated Q&A session, where attendees can unmute and engage directly with Adam and Bryce.

Register now to stay informed and get ahead of the curve on the PBM industry!

PRICING OPTIONS


Take advantage of this exclusive educational opportunity for just $420 per viewing device. Once you register, you'll receive a unique Zoom access link within 24 hours—making it easy to add the event to your calendar and ensure you don’t miss out.

Special Discounts For Teams!

We understand that many professionals are working remotely, so we’re offering substantial savings for multiple registrations from the same organization. What's more, an unlimited number of attendees can watch together at a single physical location with one registered device.

Important Reminder: Each device at a single physical location must have its own registration. The webinar may not be recorded, streamed, broadcast, or shared across different locations, devices, or sites.

Click here to register. All discounts will be automatically computed based on the number of registrations you enter in your cart. (You can reset the cart by entering 0 in the quantity field.)


Questions about corporate pricing? Please contact Marie Caldwell (mcaldwell@hmpglobal.com).

Purchasing access for multiple sites? We'll contact you for your participant list. Or, download this spreadsheet and email your registrants’ information to dcisupport@hmpglobal.com.

Payment can be made with all major credit cards (Visa, MasterCard, American Express, and Discover). Prefer check or ACH? Click here to request an invoice.

Click here for other important things to know about this event.

No comments:

Post a Comment